The Research to Revenue Workshop is designed to help faculty and students learn the practical aspects starting a biomedical/life science company. Over the course of this two-day workshop, experienced entrepreneurs will mentor attendees on how to evaluate the commercial potential of their technology, define the first steps in starting a company and assemble a startup roadmap for taking the next steps in launching the company.
The workshop is open to faculty, staff, and students from UNC, NCSU, and Duke. It is intended for early-stage University technologies for which the application is unclear. Please submit information about the technology when registering. This information will help us customize content and help select appropriate coaches. If you are not submitting information on a technology you may still attend the workshop. However, instead of meeting with a coach you attend the pitch presentations.
Throughout the course of the workshop, we will inform you on the basics of taking a technology outside the university setting, help evaluate commercial potential, identify special considerations relating to faculty entrepreneurs, review the practical steps towards starting a company, discuss the types of communication involved in venture creation and with the help of experienced coaches, develop an action plan moving forward. Learn more
Due to event expenses, this workshop is offered at a cost of $150 for faculty and $75 for students. Breakfast and lunch are included. Vegetarian options are available. However, if you have any food allergies or other dietary restrictions please let us know.
If you have any questions please contact John Sheridan (firstname.lastname@example.org)
Please note, that if you register on or after January 14th, then we will not be able to connect you with a coach for the one-on-one mentoring session.
The NC TraCS Institute at UNC-Chapel Hill is one of 60 medical research institutions working together as a national consortium to improve the way biomedical research is conducted across the country. The consortium is funded through the Clinical and Translational Science Awards (CTSA), led by the National Center for Research Resources, part of the National Institutes of Health.